Background:
Lipid accumulation in the liver, skeletal and cardiac muscle, kidneys and pancreas causes cell dysfunction, death and inflammation, a biological phenomenon named lipotoxicity. Erythrocytes participate in the transport of lipids in the circulation, and their lipidome is determined by exchange with blood components.
Objective:
To summarize the current knowledge regarding the effect of toxic lipid accumulation in erythrocytes
Results:
Erythrocyte lipidome is altered in lipotoxic diseases like fatty liver disease, heart failure, and diabetes. In addition, ceramide, lysophosphatidylcholine, lysophosphatidic acid, palmitic acid, and free cholesterol induce erythrocyte malfunction.
Conclusion:
Erythrocytes are an additional cell target of lipotoxicity. Further exploration of the implicated molecular mechanisms could lead to novel therapeutic targets for cardiometabolic and hematological diseases.